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ABSTRACT This work describes the ﬁrst cell-based model of tumor-induced angiogenesis. At the extracellular level, the
model describes diffusion, uptake, and decay of tumor-secreted pro-angiogenic factor. At the cellular level, the model uses the
cellular Potts model based on system-energy reduction to describe endothelial cell migration, growth, division, cellular adhe-
sion, and the evolving structure of the stroma. Numerical simulations show: 1), different tumor-secreted pro-angiogenic factor
gradient proﬁles dramatically affect capillary sprout morphology; 2), average sprout extension speeds depend on the proximity
of the proliferating region to the sprout tip, and the coordination of cellular functions; and 3), inhomogeneities in the extra-
vascular tissue lead to sprout branching and anastomosis, phenomena that emerge without any prescribed rules. This model
provides a quantitative framework to test hypotheses on the biochemical and biomechanical mechanisms that control tumor-
induced angiogenesis.
INTRODUCTION
Tumor-induced angiogenesis is the formation of new blood
vessels from existing vasculature in response to chemical
signals from a tumor. Angiogenesis marks the pivotal transi-
tion from benign solid tumor growth to vascular growth,
a more progressive and potentially fatal stage of cancer
beyond which cancer becomes extremely difﬁcult to treat,
existing therapies become ineffective and survival rates
decrease (1). Angiogenesis is a complex process, involving
multiple time scales and intricate interplay between bio-
chemical and biomechanical mechanisms, including cell-cell
and cell-matrix interactions, cell surface receptor binding,
and intracellular signaling pathways. The sequential mor-
phogenetic processes required for angiogenesis to occur are
well known and a review of these follows; however, what is
still not completely understood is how cellular and molecular
mechanisms are coordinated to control these processes. In
this work, we present a cell-based modeling framework of
tumor-induced angiogenesis designed to address these ques-
tions of mechanism. An understanding of the principal
underpinnings driving angiogenic processes will advance
efforts aimed at the development of new therapies for treat-
ing cancer and other angiogenesis-dependent diseases.
Tumor-induced angiogenesis
To ensure its sustained growth, a tumor must acquire a
supply of nutrients and the ability to export metabolic waste.
It does this by recruiting new blood vessels from the nearby
existing vasculature. Circulating endothelial precursors, shed
from the vessel wall or mobilized from bone marrow can also
contribute to tumor angiogenesis (2). Tumor cells can also
grow around an existing vessel to form a perivascular cuff
(3). Oxygen-deprived, or hypoxic, tumor cells are respon-
sible for releasing a wide variety of polypeptide angiogenic
factors that stimulate vessel growth toward the tumor (4).
These angiogenic factors diffuse through the surrounding
tissue, setting up a chemical gradient between the tumor and
any existing vasculature. Various molecular players are now
known to be involved in these different mechanisms of vas-
cular growth (5). Among these, members of the vascular
endothelial growth factor (VEGF) and angiopoietin family
have a prominent role (6). When VEGF reaches the blood
vessel, it triggers a cascade of events. Fig. 1 illustrates the
major VEGF-mediated events that occur during early an-
giogenesis. Endothelial cells, which form the interior lining
of blood vessels, have cell surface receptors speciﬁc to
VEGF (7). Endothelial cells are activated via two recep-
tor tyrosine kinases, FMS-like tyrosine kinase-1 and fetal
liver kinase-1, which are often referred to as VEGFR1 and
VEGFR2, respectively (8). VEGF binds to these receptors
triggering intracellular signaling pathways. One example is
the VEGF-Bcl2-CXCL8 signaling pathway, which mediates
pro-angiogenic and pro-survival phenotypes in endothelial
cells (9). Intracellular signaling leads to gene transcription,
the production of enzymes and angiogenic factors, increased
cell survival, migration, and proliferation (10).
At the onset of angiogenesis, endothelial cell activa-
tion results in increased vascular permeability (11) and the
production of proteases that locally degrade the basement
membrane of the blood vessel (12,13). This breakdown of
the basement membrane enables the endothelial cells to
migrate into the extracellular matrix of the extravascular
connective tissue, hereafter referred to as stroma. The extra-
cellular matrix (ECM) is a major component of the stroma
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and plays a central role in cellular migration, cell shape, and
orientation (14). The ECM is a meshlike molecular network
composed of ﬁbrous collagen proteins, elastin, adhesive pro-
teins, such as ﬁbronectin, and proteoglycans (see Fig. 1)
(15). To reach the tumor, endothelial cells must navigate the
stroma. Activated endothelial cells also upregulate additional
cell surface receptors integrins, which regulate cellular adhe-
sion to matrix molecules (16). To facilitate their migration,
endothelial cells have the ability to condition the ECM by
producing a number of different proteolytic enzymes that
degrade speciﬁc ECM proteins (12,13). Two such proteases
are plasminogen activators and matrix metalloproteinases.
Plasminogen activators are crucial for the degradation of
ﬁbronectin and laminin, whereas matrix metalloproteinases
degrade collagen and elastin (12,17).
There is substantial empirical evidence indicating that
VEGF induces endothelial cell migration (18–21). One
means of endothelial cell migration is by positive chemo-
taxis, which is directed motility up chemical gradients. Using
a Boyden chamber assay, Cao et al. (21) showed that VEGF
elicits a strong chemotactic response in human umbilical
vein endothelial cells. In an in vitro study of two populations
of porcine aortic cells, one cell line expressing only VEGFR1
and the other only VEGFR2 (22) demonstrated that VEGFR2
was solely responsible for VEGF-mediated chemotaxis. En-
dothelial cell migration also occurs along positive gradients
of cellular adhesion sites that are naturally present in the
ECM (23), or haptotaxis. Endothelial cell degradation of
collagen and ﬁbronectin can create new or amplify existing
local adhesive gradients, which also mediates endothelial
cell haptotaxis (24).
VEGF can regulate very different cellular responses re-
sulting in phenotypically distinct populations of endothelial
cells. In murine retinal angiogenesis, it was shown that the
sprout tip consisted of a single endothelial cell that responded
to VEGF solely by gradient-directed migration (no prolifer-
ation) and that VEGF-induced proliferation occurred only
in the cells comprising the sprout stalk, or stalk cells (19).
The mitogenicity of VEGF on endothelial cells has also been
well substantiated (7,18,21,25). From the experiments of
Waltenberger et al. (22) described above, it was again shown
that VEGFR2 was the only receptor implicated in VEGF-
stimulated endothelial cell mitosis. During angiogenesis, endo-
thelial cell proliferation provides the additional cells necessary
for the sprout to grow and extend further into the stroma to-
ward the tumor (see Fig. 1) (17,26,27). As the new sprout
approaches the tumor, branches develop when the sprout tip
splits in two and closed loops can be formed when neighbor-
ing sprouts fuse together, a process called anastomosis.
Newly formed angiogenic sprouts are initially immature (8).
Immature sprouts lack a basement membrane and are not yet
capable of supporting blood ﬂow (17). For sprouts to mature,
many other processes must ﬁrst occur, including lumen and
vacuole formation, the recruitment of specialized cells, and the
reconstruction of a basement membrane. Endothelial cells
must abandon their invasive phenotype and reassociate with
the ECMvia cell surface integrins (28). In vitro experiments of
human endothelial cells in three-dimensional collagen matri-
ces showed that vacuole and lumen formation depend on
collagen-binding integrin a2b1 (29). These studies showed
that intracellular vacuoles enlarge and coalesce to create a
luminal compartment. Endothelial cells further associate and
develop lumens at sites of cell-cell contact, thereby generating
tubular structures. Pericytes and smooth muscle cells are
recruited by endothelial cells. These cells contribute to vessel
stability and maturation by inhibiting endothelial cell prolifer-
ation and promoting new basement membrane synthesis (30).
The result is a fully mature vessel capable of blood transport
and thus nutrient delivery to the tumor.
Although the fundamental processes that occur during
angiogenesis are well established, there is still considerable
ambiguity and debate regarding how biochemical and bio-
mechanical mechanisms are coordinated to control vascular
development. Recent efforts in experimental research have
intensely focused on advancing our understanding of these
mechanisms in hopes of discovering novel anti-angiogenesis
therapies. However, as new experimental assays capable of
examining the cellular and molecular level dynamics during
angiogenesis are developed, discordant data have been pub-
lished. Below we review some of the experimental observa-
tions that have generated confusion and given rise to dogma.
Speciﬁc hypotheses are then formulated and tested with our
computational model.
VEGF isoforms
A common perception has been that a freely soluble form of
VEGF is solely responsible for both the activation and the
differentiation of function seen in endothelial cells during
tumor-induced angiogenesis. However, this belief is being
FIGURE 1 An illustration of early events in sprouting angiogenesis:
VEGF-mediated endothelial cell activation and degradation of the basement
membrane, subsequent migration and invasion into the stroma led by tip
cells extending ﬁlopodia, cell division, and endothelial cell interaction with
extracellular matrix ﬁbers. This illustration emphasizes that the processes
involved in angiogenesis are controlled at the level of individual cells. In this
context, cellular dynamics are a discrete process and a cell-based model is a
better description over continuous models, which deal with cell densities.
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revised as experiments demonstrate that sequential activa-
tion of various endothelial cell surface receptors by multiple
ligands are required for angiogenesis. Experiments show that
the same VEGF receptor (VEGFR2) is responsible for medi-
ating very different cellular functions, including endothelial
cell growth, mitogenesis, migration, and increased survival
(22,31). Some studies propose that the outcome of VEGFR2
signaling depends on the particular VEGF isoform present
(19,31). The effects of different VEGF isoforms on vascular
structure have been examined and signiﬁcantly different
capillary morphologies were observed in the presence of
matrix bound versus soluble VEGF (32). To further com-
plicate matters, other investigations have demonstrated that
local growth differentials can exist even in areas saturated
with soluble angiogenic factor (14). We intend to address the
role various VEGF isoforms play in the guidance and forma-
tion of capillary sprouts, such as: How does the binding and
release of bioavailable VEGF affect local chemical gradi-
ents? What are the respective effects on vascular structure
of diffusible and matrix-bound VEGF? What mechanisms
induce proliferation in one cell but not its neighbor? And can
the presence of matrix bound or cleaved soluble angiogenic
factors distinguish a proliferating region, possibly explaining
both the observed growth differentials and the reports of
different proliferating regions?
Proliferating region
There is convincing experimental evidence that endothelial
cell proliferation is a necessary process for tumor vascular-
ization (27). It is generally believed that during angiogenesis,
proliferation occurs right behind the tip cell and only after
the endothelial cells have already migrated into the stroma
some distance (17,27). Presently, however, discrepancies
persist concerning the precise location of the proliferating
cells during angiogenesis. Experimental models have re-
ported mitotic activity occurring at the base of a newly
formed sprout (17,33), some distance behind the sprout tip
(17,34), localized immediately behind the sprout tip cell
(17,27) and at the tip (35,36). Another area where contra-
dictory experimental data exist is whether proliferation and
migration are mutually exclusive events. Some studies have
reported that proliferation and migration are segregated
cellular functions (19,35), whereas more recent evidence
suggests that a proliferating cell does indeed migrate (33).
Cell-based modeling can assist in our understanding and
synthesis of such empirical data because it allows us to study
the impact of the location of the proliferating region on
capillary formation. To the best of our knowledge, no other
model has explored the effects of various proliferating
regions or segregation of function on capillary morphology.
Composition of stroma
The location of the tumor dictates the environment in which
endothelial cells must survive and migrate. Depending on the
tissue, the density of the matrix and the variety of other cells
that make up the stroma can vary a great deal. It is widely
accepted that cellular interactions with the ECM and the
location of the tumor have a signiﬁcant impact on new cap-
illary sprout formation and morphology. Therefore under-
standing how the ECM modulates angiogenic processes has
commanded considerable attention in experimental research.
However, there is still speculation concerning the precise
mechanisms involved; for example, what role does the ECM
play in endothelial cell function? How are growth differen-
tials between neighboring endothelial cells established? How
is sprout branching initiated? And can the composition of the
stroma be manipulated to inhibit angiogenesis? A more in-
depth investigation of the role of the composition and structure
of the stroma on capillary formation is needed and cell-based
modeling provides a forum for such studies.
Our presentation of and discussion on conﬂicting exper-
imental data suggest the following research hypotheses:
H1. The presence of matrix-bound and soluble VEGF
results in different vascular morphologies.
H2. The location of the proliferating region of cells has an
impact on capillary morphology and the rate of capil-
lary sprout extension.
H3. The composition of the stroma, such as ECM density
and the presence of other tissue cells, inﬂuences endo-
thelial cell migration and capillary formation during
angiogenesis.
MATHEMATICAL MODELS OF ANGIOGENESIS
A great number of factors must be tightly coordinated to
promote tumor-induced angiogenesis. No single model has
yet incorporated every aspect of every process involved
in sprouting angiogenesis, nor is this level of complexity
necessary for a model to be useful or predictive. Focused
investigations on particular mechanisms or processes have
led to the development of models of angiogenesis. Growth
factor-mediated protease production was modeled, incorpo-
rating an important biochemical mechanism for ECM degra-
dation and regulation of endothelial cell proliferation (37,38).
Cell-receptor-level treatment of this critical biochemical path-
way derived from ﬁrst-principle Michaelis-Menten chemical
kinetics was a signiﬁcant contribution to modeling angio-
genesis. Other advances in modeling are being achieved at a
more macroscopic level through the development of a dy-
namic adaptive tumor-induced angiogenesis model (39),
which took into account hemodynamic forces such as shear
stress and variable blood viscosity in the dynamic remod-
eling of vascular architecture. These and other existing
mathematical models offer many insights into the processes
driving angiogenesis and highlight necessary conditions for
angiogenesis to occur, such as endothelial cell proliferation,
haptotaxis, and chemotaxis (40,41), by concentrating on very
speciﬁc mechanisms inﬂuencing capillary sprout development.
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Discrete and continuum models of angiogenesis that
model sprout tip cells or cell densities are predicated on the
fact that the tip cell governs the motion of the entire capillary
sprout. Consequently, these models assume that the rest of
the cells in the capillary sprout are inactive. However, the
endothelial cells in the sprout dynamically contribute to
vascular structure through the forces of cellular adhesion,
cell signaling, and the local restructuring of the ECM (42).
To reproduce realistic vascular networks, these models must
assign probabilities to rules for branching (39–41,43). Thus,
branching was not an inherently emergent phenomenon, but
a prescribed one. Vascular networks have also been
successfully generated by modeling the mechanical proper-
ties of the ECM, such as elasticity and stiffness. A model
incorporating both chemical and mechanical forces, notably
the traction that endothelial cells exert on a viscoelastic
ECM, was able to produce vascular patterns that resemble
those observed in the in vitro experiments (44). However,
this work only considered tractile forces in a continuum
model framework and did not fully investigate the role of
chemotaxis and sprouting vessels in tumor-induced angio-
genesis. Another leading effort in modeling tumor-induced
angiogenesis is described in Sun et al. (45), where they
explicitly modeled the anisotropy and heterogeneity of the
ECM and were able to capture the dendritic structure of
capillary network formation. However, sprout branching still
only occurred as a result of imposed rules. A new branch was
generated when both the age of the sprout is above some
prescribed age and the variation of the tip velocity transverse
to the existing sprout orientation is greater than a certain
threshold value. Although the structure of the ECM was
incorporated into their model, direct endothelial cell-matrix
interactions were not, and consequently, the model was
unable to capture the individual cell dynamics that allow
cells to respond differently according to their speciﬁc local
microenvironment.
Cell-based modeling
Fig. 1 emphasizes that the processes involved in angiogen-
esis happen at the level of individual cells. A cell-based
model is able to account for individual cell interactions with
and inﬂuence on their local environment. Consequently, cell-
speciﬁc biochemical and biomechanical dynamics are easily
incorporated. In addition, because the typical sprout is only a
few endothelial cells wide, cell-based modeling provides a
better description of the cellular dynamics during early
angiogenesis than continuum models, which deal with cell
densities. In this ﬁrst report of our new model, we do not
attempt to introduce every dynamic known to inﬂuence
angiogenesis. The primary aim of our investigation is to
understand the roles of cell-cell and cell-matrix interactions
on sprouting angiogenesis. We therefore focus only on those
speciﬁc cell-cell and cell-matrix dynamics that occur at the
onset of angiogenesis. We also incorporate several key
biochemical dynamics: 1), VEGF binding to, internalization,
and recycling of endothelial cell surface receptors; 2),
VEGF-mediated cellular activation, migration, and prolifer-
ation; and 3), proteolytic extracellular matrix degradation.
Another advantage to cell-based modeling is that adding
another scale to the system, for example by incorporating
intracellular signaling as was done in Jiang et al. (46),
is a relatively straightforward extension of the model.
Intracellular events downstream of VEGF binding to endo-
thelial cell surface receptors are not crucial to our present
investigations of cell-cell and cell-matrix interactions and
therefore are not explicitly treated in this model. However,
intracellular signaling will be an important consideration for
more in-depth investigations of the biochemical mechanisms
controlling angiogenesis, and the results obtained here will
be used to help discern which intracellular signaling
pathways are necessary to include in future extensions of
this model. In addition, because our attention is on the early
events in sprouting angiogenesis, our simulated sprouts are
not fully mature vessels that are capable of supporting blood
ﬂow. However, as was shown in Kearney et al. (33), blood
ﬂow is not required for branching and anastomosis to occur
and thus, at this stage, we do not consider the effects of blood
ﬂow in our model.
In this work, we concentrate on: 1), developing a cell-
based approach to modeling growth, division, and migration
during early angiogenesis; 2), incorporating the key bio-
chemical and biomechanical interactions occurring between
endothelial cells and the ECM; and 3), investigating the
mechanisms responsible for generating realistic capillary
structures, including branching and anastomosis, without a
priori prescribing rules and probabilities to these events. Our
model is distinct from previous models of tumor-induced
angiogenesis in several ways. First, this model captures
single cell biochemical and biomechanical dynamics allow-
ing individual cells to interact with and inﬂuence their local
environment. This model constitutes the ﬁrst cell-based
model of tumor-induced angiogenesis. Second, we explicitly
model the stroma, including structural variations, such as the
anisotropy of the matrix ﬁber distribution and tissue speciﬁc
cells. Third, we distinguish between sprout tip and stalk cells
and incorporate the distinct behavior each cell phenotype
exhibits. Finally, our major result is that this model is
capable of simulating capillary sprout branching and anas-
tomosis, larger-scale structures that emerge only as a result
of the featured cellular and molecular level dynamics; no
rules speciﬁcally incorporating branching or anastomosis are
imposed.
This article is organized in the following manner. We ﬁrst
present our new cell-based model of tumor-induced angio-
genesis. We then present results from numerical simulations
demonstrating the capability of this model to produce
realistic capillary structures. We further use the model to
test the hypotheses formulated above and report our ﬁndings.
A discussion and summary conclude our communication.
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CELL-BASED MODEL OF
TUMOR-INDUCED ANGIOGENESIS
Model architecture
The processes involved in angiogenesis naturally suggest a
three-tier time and length scale architecture. We have de-
veloped a cell-based model structured in terms of these mul-
tiple scales by incorporating extracellular and intercellular
environments. An intracellular level can be added to incor-
porate signaling pathways that control cell cycle and other
signaling dependent decisions that occur inside the cells.
This is the subject of future work. Our model utilizes the
advantages of both discrete and continuous modeling. At the
extracellular level, a partial differential equation describes dif-
fusion, uptake, and half-life decay of tumor-secreted VEGF.
At the cellular level, a discrete lattice Monte Carlo model (the
cellular Pottsmodel) considers cellmigration, growth, prolifer-
ation, cellular adhesion, and extracellular matrix degradation.
The extra- and intercellular environments are integrated and
directly impact each other.
Model domain and geometry
We initiate the simulations with a single endothelial cell,
which has degraded the basement membrane of the primary
blood vessel that lies adjacent to the left hand boundary.
Adjacent to the right-hand boundary, an avascular tumor is
situated which delivers VEGF to the stroma. Fig. 2 shows the
initial conﬁguration and geometry of the domain. Using a
two-dimensional domain provides a ﬁrst approximation to
capillary sprout formation in vivo and allows us to compare
our results with both planar experimental models (e.g.,
(32,36,47) and other two-dimensional computational models
(41,43,45). Our model has the ﬂexibility to examine capil-
lary sprout development at different length scales. The
avascular cornea of the rodent eye is a classical angiogenesis
assay, which allows the process of neovascularization to
occur over long distances (1–2 mm) (35,48). However, tu-
mors forming in other tissues, for example in the lung, brain,
stomach, and breast, are typically much closer to the existing
vasculature. Since our interest is on individual cell interac-
tions during early sprouting angiogenesis, and sprout initia-
tion and branching have been shown to occur over distances
ranging from 20 to 100 mm (32,33), in our model, the dis-
tance between the parent blood vessel and the tumor is;165
mm. This distance is slightly larger than the diffusion limit
for oxygen (;100 mm). We choose this length scale so that
we can focus on cell-cell and cell-matrix interactions, to
replicate the hypoxic conditions that may arise in vivo, and
to allow sufﬁcient space for the new sprouts to grow 100 mm
without encountering an artiﬁcial boundary.
Extracellular environment
The evolution of VEGF sets up a chemical gradient between
the tumor and the parent blood vessel and constitutes the
extracellular environment to which the endothelial cells
respond. VEGF is secreted by the tumor and diffuses through
the stroma where it decays at a constant rate and is taken up
by endothelial cells. Mathematically, the spatial proﬁle of
VEGF satisﬁes a partial differential equation of the form
@V
@t
¼ D=2V  lV  Bðx; y;VÞ; (1)
where V ¼ V(x, y, t) denotes VEGF concentration. The
coefﬁcient of diffusivity for VEGF in tissue, D . 0, is
assumed to be homogeneous throughout the simulation do-
main. The rate VEGF decays, l . 0, is also assumed to be
constant, and B(x, y, V) is a function describing endothelial
cell binding and uptake of VEGF.
The maximum amount of VEGF that can be bound and
internalized by an endothelial cell per unit of time is denoted
by b. To compute b, we consider the number of VEGF
receptors per endothelial cell and the rate at which VEGF-
receptor complexes can be internalized and surface receptors
recycled. Vascular endothelial cells express both VEGFR1
and VEGFR2. While VEGFR2 is VEGF-speciﬁc, VEGFR1
is not and can bind adhesion molecules and other growth
factors (49). However, in this model, we do not consider
multiple VEGF isoforms or growth factors, or the explicit
binding of adhesion molecules, both of which compete for
available binding sites. Thus, in our calculation of b, we use
the total number of VEGFR1 and VEGFR2 receptors per cell
(311,200 (50)), an instantaneous VEGF-receptor complex
internalization rate of 4.3 3 104 per second, and 45 kDa as
the molecular weight for VEGF165 (7,49). The value of b is
given in Table 1. Receptor binding occurs very rapidly com-
pared to the timescale of endothelial cell migration and pro-
liferation. Thus, we assume that an endothelial cell instantly
binds an amount of VEGF equal to the lesser of available
FIGURE 2 The geometry of the initial domain. An EC bud (dark gray)
protrudes into the domain from the parent blood vessel on the left; an
avascular tumor resides outside the domain on the right-hand side and
supplies VEGF to the stroma. The space between represents the stroma and
is composed of extracellular matrix ﬁbers (light gray), tissue-speciﬁc cells
(black), and interstitial ﬂuid (gray).
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chemical concentration V or the maximum amount that can
be bound to endothelial cell surface receptors and internal-
ized, b. This function is given by
Bðx;y;VÞ¼
b; ifb#V andfðx;yÞ  endothelialcellg;
V; if 0#V, bandfðx;yÞ  endothelialcellg;
0; if fðx;yÞ<endothelial cellg:
8<
:
Initially, there is no VEGF in the stroma. The amount of
VEGF supplied to the right-hand boundary of the domain
was estimated by assuming that in response to a hypoxic
environment, quiescent tumor cells secrete a constant amount
of VEGF and that VEGF decays at a constant rate. It is
reasonable to assume that the concentration of VEGF within
the tumor has reached a steady state and therefore that a
constant amount of VEGF, denoted S, is available at the
boundary of the tumor. VEGF secretion rates for hypoxic
human cancer cells were taken from experiments (4) and the
number of quiescent cells secreting VEGF was estimated
based on the total number of quiescent cells in an avascular
tumor as measured in Jiang et al. (46). At a distance of 165
mm and given that an avascular tumor grows to;1–2 mm in
diameter (28), the supply of VEGF from the tumor can be
approximated by a line source. Accordingly, the following
initial and boundary conditions were used:
Vðx;y;0Þ ¼ 0;
Vð0;y; tÞ ¼ 0; VðL1;y; tÞ ¼ S; Vðx;0; tÞ ¼ Vðx;L2; tÞ:
These initial and boundary conditions for VEGF have
frequently been employed in previous models of tumor-
induced angiogenesis (43,51,52). A dimensional analysis
indicates that the concentration of VEGF in the stroma will
also very quickly reach a steady-state proﬁle due to the fast
diffusion. Numerical computations conﬁrm this. Conse-
quently, the steady-state solution is a good approximation to
Eq. 1 and we use the steady-state VEGF proﬁle as an initial
condition for the discrete model as was similarly done in the
literature (41,43).
Modeling the stroma and extracellular matrix
The explicit modeling of the stroma and the extracellular
matrix ﬁbers is a novel feature of this model. The stroma is
composed of matrix ﬁbers, interstitial ﬂuid, and tissue-
speciﬁc cells creating an inhomogenous composition and
structure. We include tissue cells in our model to mimic a
more anatomically accurate extracellular environment for the
growing and migrating endothelial cells. The properties
associated with these cells are tissue-speciﬁc and depend on
the particular biological processes being studied. For exam-
ple, specialized cells, such as mast cells, ﬁbroblasts, macro-
phages, or pericytes, could be modeled to capture the effects
of other guidance cues on sprout formation or to examine
their roles in sprout maturation and stability. Our current
focus is to study how the composition of the stroma affects
sprout morphology and migration, and therefore, at this stage
a ‘‘general’’ tissue cell is modeled to provide an additional
level of structure to the stroma. We assume that tissue cells
are roughly the same size as an endothelial cell (15), are
immobile, and are more difﬁcult to invade than matrix ﬁbers
and interstitial ﬂuid. Consequently, tissue cells compete for
space and create intercellular pressure on and resistance to
the migrating and proliferating endothelial cells. Matrix
ﬁbers comprise ;37% of the stroma and the architecture of
the ECM is anisotropic, with regions of varying densities
(15). A single collagen ﬁbril is ;300-nm long and 1.5-nm
wide and is substantially smaller than an endothelial cell,
which is ;10 mm in diameter (15). Thus, to model the
meshlike anisotropic structure of the ECM, we assume that
many individual collagen ﬁbrils and other matrix proteins are
bound together constituting larger cords or bundles of matrix
ﬁbers that have been estimated to be between 100 and 1000-
nm thick (53). We randomly distributed 1.1-mm-thick ﬁber
bundles at randomly chosen discrete orientations ranging
from 0 to 180 until 37% of the stroma was occupied.
TABLE 1 Table of parameters
Parameter Symbol Dimensions Model value
VEGF diffusion D L2/T 3.6 3 104 cm2/h (62)
VEGF decay l T1 0.6498 h1 (62)
VEGF uptake b M/cell/T 0.06 pg/EC/h (49,50,63)
VEGF source S M/L 0.035 pg/pixel (4,46)
Activation threshold va M 0.0001 pg
Proliferation threshold vp M 0.005 pg
Adhesion
EC–EC Jee E/L 1
EC–ﬂuid Jef E/L 32
EC–matrix Jem E/L 16
EC–tissue Jet E/L 31
Fluid–ﬂuid Jff E/L 35
Fluid–matrix Jfm E/L 35
Fluid–tissue Jft E/L 32
Matrix–matrix Jmm E/L 5
Matrix–tissue Jmt E/L 30
Tissue–tissue Jtt E/L 2
Membrane elasticity
EC* ge E/L
4 1.0
Matrix gm E/L
4 0.4
Fluid gf E/L
4 0.1
Tissue cell* gt E/L
4 1.2
Chemotaxis* m E/conc –1.5 3 105
Boltzmann temperature kT E 0.01
Dimensions are given in terms of L ¼ length, T ¼ time,M ¼ mass, and E ¼
energy. For instance, the adhesion terms have dimensions of energy per unit
length of cell membrane. An asterisk (*) designates a parameter that has
been varied across numerical experiments; all other parameters were held
ﬁxed. The exact parameter values used in a simulation are given in the
discussion corresponding to that experiment. Unless otherwise noted, all
simulations used the same parameter set, initial conﬁguration of matrix
ﬁbers and tissue cell distribution, and follow the assumptions described in
the previous section. EC denotes endothelial cell.
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Cellular Potts model for cellular dynamics
The processes involved in new capillary formation occur at
the level of individual cells. Accordingly, we use the cellular
Potts model to model the interactions between endothelial
cells or between an endothelial cell and the stroma (matrix
ﬁbers, tissue cells, and interstitial ﬂuid). The cellular Potts
model is a discrete lattice Monte Carlo model developed by
Glazier and Graner and is based on an energy minimization
principle (54). The cellular Potts model has already been
used to model a multitude of biological phenomena includ-
ing differential adhesion-driven cell rearrangement (54),
cellular differentiation and growth of tissues (55), fruiting
body formation ofDictyostelium (56), avascular tumor growth
(46), cancer invasion (57), and vasculogenesis (58, 59).
In this work, we extend the cellular Potts model to simu-
late tumor-induced angiogenesis. Our work is distinct from
that presented in the literature (58,59), which modeled the
reorganization of randomly dispersed cells into a vascular
network pattern, simulating in vitro vasculogenesis. In con-
trast, our work focuses on the processes that generate the
sprouting of new capillaries from a preexisting vasculature in
vivo (angiogenesis). Moreover, our model considers cell
growth and division, dynamics that are not modeled in the
literature (58,59), and we explicitly model the ECM, a com-
ponent critical to vascular formation.
The cellular Potts model partitions the computational
domain into endothelial cells, matrix ﬁbers, tissue cells, and
interstitial ﬂuid which are situated on a lattice and are denoted
by type t¼fe,m, t, fg, respectively. To account for individual
cells, each cell is further associated with a unique identifying
number, denoted by s, that is assigned to every lattice site
occupied by that entity (see Fig. 2 in (56) for an example).
Matrix ﬁbers and interstitial ﬂuid are collectively identiﬁed by
1 and 0, respectively. Under this framework, each entity has a
ﬁnite volume, a deformable shape, and competes for space.
Intercellular interactions occur only at the cell’s surface and
have a cell-type-dependent surface (or adhesion) energy
given by Jt, t9, which is a measure of the coupling strength
between the entities t and t9. Cellular dynamics are charac-
terized by an equation for total energy given by
E¼ +
sites
Jt;t9ð1ds;s9Þ1 +
cells
gt asATs
 2
: (2)
The ﬁrst term in Eq. 2 is the contribution to total energy
resulting from cell adhesion at cell surfaces. The second term
takes into account the fact that cell growth and deformation
require energy, where as denotes cell s’s current volume and
ATs is a designated ‘‘target’’ volume. We assume that the
target volume of an endothelial cell undergoing mitosis is the
volume that it would grow to in the absence of external
forces and given sufﬁcient nutrition, and is designated as
twice its initial volume.
Additionally, we know that VEGF acts as a chemoattrac-
tant for endothelial cells (20). The effective energy required
for chemotaxis, DEChemotaxis, can be derived as follows: In
our model, cell movement is governed by energy gradients
and, over time, cells move to reduce the total energy of the
system. Empirical evidence indicates that VEGF concentra-
tion gradients induce endothelial cells to move in the direc-
tion of increasing concentration with a velocity proportional
to the VEGF gradient. Because the cells must move through
the highly viscous ECM, their motion is overdamped and
the force required for motion is proportional to velocity,
F~Chemotaxis}~y. Consequently, the force is proportional to the
chemical gradient. We can construct an effective chemotaxis
potential that is proportional to the local chemical gradient:
DEChemotaxis ¼ms½Vðx~ÞVðx~9Þ: (3)
The parameter ms , 0 is the effective chemical potential,
which inﬂuences the strength of chemotaxis relative to other
parameters in themodel. The values x~9 and x~represent the two
neighboring lattice sites randomly selected during one trial
update in a Monte Carlo step, which is described in detail
below.
The cellular Potts model evolves in time using repeated
probabilistic updates of unique cell identiﬁcation numbers,
s, on the lattice. Procedurally, a lattice site, x~, is selected at
random and assigned the s from one of its unlike second
nearest neighbors, x~9, which has also been randomly se-
lected. The total energy of the system is computed before and
after the proposed update. If the total energy of the system is
reduced as a result of the update, the change is accepted. If
the update increases the energy of the system, we accept the
change with a Boltzmann probability. Thus the probability of
accepting an update is given by
Pacceptance ¼ 1; ifDE,0;eDE=kT; ifDE$0;

where DE is the change in total energy of the system as a
result of the update, k is the Boltzmann constant, and T is the
effective temperature that corresponds to the amplitude of
cell membrane ﬂuctuations. This probability inﬂuences the
likelihood of energetically unfavorable events taking place
(57). A total of n proposed updates, where n is the number of
sites on the lattice, constitutes one Monte Carlo step and is
the unit of time used in the model.
In the model, endothelial cells will move to promote
stronger over weaker adhesive bonds, shorter over longer cell
boundaries, and toward regions of higher chemical concen-
trations. Only endothelial cells are allowed to grow,move and
invade; ECM, tissue-speciﬁc cells and interstitial ﬂuid do not
grow or actively invade each other or endothelial cells.
Endothelial cells interact both mechanically and biochemi-
cally with the ECM. Effective mechanical forces exerted on
the ECM by endothelial cells as they migrate are incorporated
as a result of thematrix ﬁbers’ resistance to compression given
by gm. Biochemical interactions include VEGF binding to,
uptake by, and activation of endothelial cells, endothelial cell
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matrix degradation, and the chemical bonds between en-
dothelial cells and between endothelial cells and matrix ﬁ-
bers, which are accounted for by Jee and Jem, respectively.
Haptotaxis is naturally incorporated through this adhesion
termwhenever an endothelial cell interactswith amatrix ﬁber.
The endothelial cells also interact with the tissue cells via
surface adhesion and competition for space. Each endothelial
cell additionally carries its own internal cell clock, which is
used to determine where the cell is in its mitotic cycle and
whether or not cell division can occur. The endothelial cell
cycle is not explicitlymodeled, but thismodel can bemodiﬁed
to incorporate intracellular signaling cascades regulating the
cell cycle and cell cycle-dependent events as was done by
Jiang et. al. (46) in their multiscale model of avascular tumor
growth. Cell division occurs when a proliferating cell has
doubled in size and has gone through one complete cell cycle,
which we take to be 18 h (60). Cell division produces two
daughter cells; one daughter cell keeps the cell ID of the parent
and the other is assigned its own unique ID. Because endo-
thelial cells demonstrate an increased rate of survival in the
presence of VEGF (61), endothelial cell death is not con-
sidered in the model.
Our model also distinguishes between tip and stalk cell
phenotypes (19). A tip cell is deﬁned as the leading endo-
thelial cell and when activated by VEGF, the tip cell migrates
chemotactically using the matrix ﬁbers for support. The tip
cell is also capable of degrading the matrix ﬁbers, thereby
establishing local adhesion gradients and further promoting
its migration through the stroma (23,24). Proliferation occurs
behind the tip cell (17,27) and this phenomenon is captured
by allowing those stalk cells to proliferate. We further as-
sume that if the cell is proliferating, it cannot move chemo-
tactically (17,19,35) and vice versa. The remaining stalk cells,
as long as they are VEGF-activated, only move in response
to cell-cell and cell-matrix adhesion, and through random
membrane ﬂuctuation.
Hybridization: interfacing the discrete and
continuous models
The continuous model describing the VEGF proﬁle and the
discrete model of cellular dynamics are used as initial con-
ditions for each other at every time step to produce a coupled
system of extra- and intercellular dynamics. At time zero,
the steady-state solution to Eq. 1 deﬁnes the initial VEGF
proﬁle used in the discrete cellular model. Within the discrete
model, each endothelial cell uniquely responds to the amount
of VEGF present by deciding whether there is sufﬁcient
VEGF to become activated. VEGF must be present in quan-
tities above a threshold level, va, for endothelial cell activa-
tion to occur. Once activated, each individual endothelial cell
decides whether it is a tip cell and will migrate and degrade
the ECM, or if it is a proliferating cell, and will grow and
divide. After the discrete model evolves through one Monte
Carlo step in time, the function for endothelial cell VEGF
uptake and binding, B(x, y, V), is rederived based on the new
distribution of endothelial cells on the lattice. A new spatial
proﬁle for VEGF at the next time step is obtained by solving
Eq. 1 using the updated function B(x, y, V). The lattice is then
updated with the new VEGF proﬁle. As the continuum and
discrete models feed-back on each other, each endothelial
cell responds to its evolving microenvironment.
Parameters
Whenever possible, we take parameters from experimental
data. A list of all parameter values used in our model is
provided in Table 1, including references. If no reference is
given, the parameter is a relative value chosen to emulate
observed phenomenological behaviors. By equating the time
it takes an endothelial cell to divide during the simulation
with the endothelial cell cycle duration of 18 h, we calibrate
Monte Carlo steps to real time units. In the simulations, one
Monte Carlo step is equivalent to 1 h.
The value for endothelial cell activation va is based on our
numerical solutions to Eq. 1 and is chosen to activate the
initial endothelial cell. A smaller relative value for Jt,t9 es-
tablishes a stronger cell surface bond. Endothelial cells will
bind more tightly to each other than they will with other
constituent types, whereas interstitial ﬂuid has very little
binding afﬁnity. The membrane elasticities, gt, are chosen to
reﬂect the relative compressibility of the constituent. A larger
value makes it more difﬁcult for a constituent to deviate from
its target volume and consequently more difﬁcult to invade.
Interstitial ﬂuid is relatively easy to invade compared to the
tissue-speciﬁc cells. The chemotactic potential, ms, is chosen
so that its contribution to total energy is on average equal to
the contribution to total energy due to cell growth.
RESULTS
Realistic capillary sprout morphology captured
Fig. 3 depicts a typical simulation demonstrating the model’s
ability to reproduce realistic capillary sprout morphologies.
So that we could attribute any changes in sprout morphology
directly to the mechanism or parameter being tested, unless
otherwise noted, all simulations used the same parameter set,
initial conﬁguration of matrix ﬁbers and tissue cell distribu-
tion, and follow the assumptions described in the modeling
section. Sprout migration is facilitated as the tip cell degrades
the matrix ﬁbers and effectively migrates via haptotaxis up
these local adhesion gradients. Comparing simulations with
and without ECM degradation, we found that tip cell ECM
degradation increased the average rate of sprout extension
toward the tumor by 5%, a small but statistically signiﬁcant
effect. The resulting morphology of the capillary sprout is
determined by several mechanisms: tip cell migration toward
positive VEGF and adhesion gradients, cellular adhesion to
the ECM, and competition for space. Coordination of or
3112 Bauer et al.
Biophysical Journal 92(9) 3105–3121
competition among these mechanisms affects cell shape and
orientation and can be readily observed during movies of
the simulations (Supplementary Material, Movie S1). For
instance, interplay between haptotaxis and chemotaxis can
result in endothelial cell elongation, a characteristic cell
shape for migrating cells, without needing a rule prescribing
an elongated cell shape as was done in Merks et al. (59)
(arrow in Fig. 3).
Whenever possible, we make every effort to compare cell
and sprout dynamics and morphologies observed during
simulations with observations from experimental assays. On
average the capillary sprouts are 14.2 6 2.44 mm (mean 6
SD) in diameter and 1–2 cells wide, which compares quan-
titatively well to VEGF-induced vessel diameters reported in
the literature (32,64). We have quantiﬁed and report the rates
of sprout extension under various simulation conditions.
Sprout length is determined by measuring the distance from
the center of mass of the initial endothelial cell at the base of
the sprout to the tip cell’s center of mass at the end of the
simulation. Average sprout extension velocity is then calcu-
lated as the ﬁnal sprout length over time. Sprout extension
rates are presented and discussed in a subsection below.
In the Introduction, several key hypotheses were formu-
lated that were driven by confusing or conﬂicting results
from empirical data. In the following subsections, we use our
model to test these hypotheses by relaxing the relevant
baseline assumption(s) set forth in the model description.
Local VEGF gradient inﬂuences
capillary morphology
Recent studies have focused on the role of various VEGF
isoforms in cellular function (19,49) and morphogenesis (32)
and have found that VEGF in soluble versus bound form has
a different effect on vascular appearance. There is evidence
that steep VEGF gradients can be generated due to either
high matrix binding afﬁnity isoforms or as a result of addi-
tional soluble VEGF cleaved from the matrix (19,32,65).
Since we model capillary sprout formation starting from a
single cell, cell densities in our simulations are very low. Our
numerical solutions to Eq. 1 show that cell uptake of diffus-
ible VEGF for low cell densities has only a very slight effect
on the chemical proﬁle at any time. Consequently, only very
shallow gradients of freely diffusible VEGF are established.
Other mathematical models of angiogenesis (37,45) have
simulated steep chemical gradients, but these are formed
strictly as a result of VEGF consumption by a large number
of endothelial cells. In addition, different tumor geometries
(linear versus circular) have been simulated which also pro-
duced different VEGF gradients (43). However, all of these
models focus on the effects of VEGF gradients on capillary
network development and vascular patterning. They were
not able to explore the effects of different VEGF gradients on
individual cells (sprout stalk and tip cells) or on changes in
sprout morphology that occur as a result of single cell dynam-
ics. Using our model, we investigate the effects of different
VEGF gradient proﬁles on cellular function and how cellular
function affects sprout morphology.
In this investigation, we do not explicitly model different
isoforms or the binding of VEGF to the matrix. Instead,
shallow VEGF gradients are constructed by assuming endo-
thelial cells bind a diffusible VEGF isoform. The resulting
gradients are very shallow (Fig. 4 a). To mimic a VEGF iso-
form that is sequestered in the ECM, we begin with the same
initial VEGF proﬁle but do not provide a source of VEGF as
before. Consequently, once an endothelial cell binds to and
internalizes a VEGF molecule, VEGF is depleted over time,
thereby establishing steep local concentration gradients (Fig.
4 c). As in our baseline simulations, each cell decides
independently whether or not it has enough VEGF to become
activated, va. Now an activated cell additionally decides
whether there is enough VEGF present to stimulate prolif-
eration, vp. We no longer specify a proliferating region just
behind the sprout tip, but allow instead VEGF concentration
dependent endothelial cell proliferation (19). No experimen-
tal data is available for the threshold amount of VEGF
required for proliferation, therefore we choose a value to
stimulate proliferation ;48 h after the initial cell began
migrating into the stroma (17,27). If there is insufﬁcient
VEGF, a cell will deactivate and become inert.
Fig. 4 b shows the endothelial cell response to soluble
VEGF. As the sprout grows, a greater number of endothelial
cells are activated and stimulated to proliferate (Supplemen-
tary Material, Movie S2). Because more cells are growing,
the entire sprout is on average 46% larger and the sprout
is more invasive. The average diameter of the sprout was
60 mm. Furthermore, because only shallow gradients are
formed, the tip cell does not have strong directional preference
from chemoattractant gradients. The resulting morphology is
FIGURE 3 Representative simulation showing the model’s ability to re-
produce realistic capillary sprout morphologies. Sprouts migrate along ma-
trix ﬁbers up chemical gradients of VEGF. The structure of the matrix guides
sprout migration and affects cell shape and orientation. The arrow identiﬁes
a cell that has elongated due to chemotactic forces and adhesion to the
matrix. Parameters used are given in the parameter table except ge¼ 0.7 and
gt ¼ 0.8. Snapshot at 16.6 days.
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a swollen sprout, a morphology consistent with vascular
hyperplasia (32). We also see lateral and backward cell
movement following adhesive gradients. Backward migra-
tion, or migration back toward the parent vessel, is an
observed phenomenon in vivo (see Fig. 1 in (45)) and was
also numerically simulated in Sun et al. (45). Fig. 4 d depicts
the capillary morphology that results from steep extracellular
gradients of matrix-bound VEGF. The morphology is strik-
ingly different. As VEGF is depleted, there is a reduction
in the size of the proliferating region and some cells even-
tually became inactive. Additionally, steep gradients provide
strong migrational cues to the tip cell and the result is a less
invasive sprout with an average diameter of 20 mm. For
shallow gradients, increasing the proliferating threshold ef-
fectively introduced a delay in the dynamics; however, in
both cases, the ultimate capillary morphology is unchanged.
The morphologies we observe agree well with the experi-
mental observations in Lee et al. (32), which tested the
angiogenic responses to different VEGF isoforms in vivo.
They demonstrated that endothelial cell receptor activation
by soluble VEGF induced signiﬁcant cell proliferation and
broad invasion of the stroma (vessel diameter of 109 mm),
whereas receptor activation by matrix-bound isoforms re-
sulted in ﬁlopodia extension, limited stromal invasion, and
cell-cell associations consistent with sprouting angiogenesis
(vessel diameter of 15 mm). Moreover, endothelial cells in
shallow VEGF gradients lose their directional guidance cues
(19). This observation agrees with the results of Gerhardt
et al. (19), where tip cell ﬁlopodia lost their polarity and
excessive ﬁlopodia extend from stalk cells in response to
shallow gradients of VEGF in transgenic mice expressing
only VEGF120.
FIGURE 4 The markedly different capillary sprout morphologies that result from shallow (a) versus steep (c) VEGF gradients. Swollen, invasive sprouts
result from shallow VEGF gradients that develop when freely soluble VEGF is expressed (b), whereas when matrix-bound VEGF isoforms are assumed, steep
gradients develop and result in narrower capillary sprouts (d). Both results concur with the experimental observations of Lee et al. (32). Parameters are given in
the parameter table. Snapshots at (b) 9.4 and (d) 16.6 days.
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Average rates of sprout extension are affected
by proliferating region and cooperation of
cellular functions
As discussed previously, experimental models have reported
conﬂicting results regarding the precise region of proliferating
cells during angiogenesis. We use our model to investigate
the effects of various proliferating regions on capillary mor-
phology and on the average rate of sprout extension toward
the tumor. We look at capillaries that develop with prolif-
eration occurring:
1. Only at the tip of the growing sprout.
2. Immediately behind the sprout tip.
3. Three cell lengths behind the advancing tip.
4. At the base of the sprout.
Because newly formed sprouts have not yet resynthesized
a basement membrane, proliferation in these different
regions is biologically feasible. Empirical evidence quanti-
fying the distribution of cell divisions during sprout forma-
tion showed that proliferation can occur at the tip, behind the
tip, and at the base of newly formed sprouts (33). As in our
baseline simulations, if a cell is proliferating, it does not
move chemotactically. We run all simulations for the same
duration and use the same parameter set.
Among the proliferating regions tested, we ﬁnd no marked
differences in sprout morphology. Fig. 5 shows the resulting
sprouts when proliferation occurred at the base (top inset)
and at the tip (lower inset) of the sprout. Fig. 5 also shows the
relationship between the proximity of the proliferating re-
gion to the tip and sprout extension speeds toward the tumor.
The data indicate that as the proliferating region moves fur-
ther away from the migrating tip, the average rate of sprout
extension toward the tumor increases. These results suggest
some interplay or competition between the mechanical or
biochemical forces exerted by the migrating tip and the
proliferating cells. Migrating cells move toward the source of
chemoattractant and the cells adhered to it are pulled along.
On the other hand, proliferating cells do not necessarily
grow directly toward the chemical source. This is because it
requires less energy for the cells that make up the capillary
sprout to grow into matrix and ﬂuid than to invade the space
occupied by other cells. In addition, a proliferating cell does
not migrate and consequently anchors neighboring cells via
cell-cell adhesion. When a proliferating cell is adjacent to a
migrating cell, each phenotype has to overcome the forces
exerted by the other. However, once the proliferating region
is far enough away, there is no statistically signiﬁcant change
in sprout extension speed, suggesting that the forces exerted
by each phenotype have only short-range effects.
To investigate the validity of this explanation, we perform
a numerical experiment identical to Experiment 1, above,
except that migration and proliferation are no longer inde-
pendent and exclusive cellular events. It has been shown
empirically that proliferation and migration are not isolated
cellular functions (33). We ﬁnd that when proliferating cells
also move chemotactically, the average rate of sprout ex-
tension increases to 7.7 mm/day, signiﬁcantly faster than any
of the speeds observed for all proliferating regions tested.
This rate represents a 36.5% increase above the rate observed
in Experiment 1 and a 7.4% increase over the fastest average
speed observed (Experiments 1–4). This ﬁnding supports the
view that proliferating and migrating cells exert short-range
competing forces on each other and further suggests that
coordination of these cellular functions could have a signif-
icant effect on the rate of capillary extension. Our examination
does not rule out the possibility that multiple proliferating
regions may exist.
Stroma composition and ECM structure:
mechanisms for capillary sprout branching
and anastomosis
As shown in Fig. 6 a, our model is able to reproduce
branching structures. An exciting feature of this model is that
branching occurs naturally as a result of known cellular
and molecular level dynamics, not as a result of predeﬁned
probabilistic rules. To our knowledge, no other model has
simulated sprout branching without a priori prescribing a
phenomenological rule. Movies of capillary sprout evolution
are evaluated to examine the possibility that heterogeneities
in the stroma induced branching (Supplementary Material,
Movie S3). We observe that the direction of sprout migration
is predominantly determined by chemotaxis and endothelial
cell adhesion to and movement along the matrix ﬁbers. As
FIGURE 5 The relationship between the average rate of sprout extension
and the location of the proliferating region. The further the proliferating
region from the migrating tip, the faster the average rate of sprout extension
due to the interplay between the chemotactic forces exerted by the migrating
tip and competition for space by the proliferating cells. Error bars represent
standard deviations from the mean using a sample of 12 simulations.
Parameters used are as given in the parameter table except ge ¼ 0.7 and
gt ¼ 0.8.
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the leading cells encounter variable matrix densities and
other stromal cells, the sprout changes direction to ﬁnd a
path of lower resistance through the stroma. Regions of
higher density matrix impose a barrier to forward migration,
whereas regions of relatively low densities do not provide
enough adhesion or cellular support for migration. Both ex-
tremes cause the sprout to change direction and lead to more
tortuous sprout morphologies. We hypothesize that anisot-
ropies in matrix ﬁber structure or intercellular pressure by
tissue cells provides an opportunity for the redirection of the
entire sprout or of individual cells. It is possible that it is this
redirection or migration of individual cells that leads to
branch formation. Whether or not a branch emerges depends
on the combination of local forces acting on the individual
cells. Forces induced by cell-matrix adhesion coupled with
chemotaxis or intercellular pressures may facilitate cellu-
lar migration away from the main body of the developing
sprout. Compared to other models of tumor-induced angio-
genesis that simulate the ‘‘brush border’’ effect (43,45),
which is an increased incidence of branching as the sprout
approaches the tumor (48), the length of our computational
domain is much shorter. Consequently, we do not expect to
reproduce the brush border effect captured on longer length
scales (1–2 mm) that allow multiple branching points to
form.
To investigate the possibility that the tessellated structure
of the stroma may have generated the observed capillary
sprout branching, we conduct three additional numerical
experiments: sprout formation 1), in the absence of tissue-
speciﬁc cells; 2), in the absence of matrix ﬁbers; and 3),
within a homogeneous extravascular environment (no matrix
and no tissue cells). We then examine the effects of altering
the compressibility of the tissue cells. All simulations are
identical except for the absence of tissue cells or matrix
ﬁbers. Fig. 6, b–d, shows representative ﬁnal images from
numerical experiments 1–3, respectively. In the ﬁrst exper-
iment, we completely remove the tissue cells from the
stroma. Fig. 6 b shows that a branch still emerges, but in this
case it develops solely in response to chemotactic gradients
and cell-matrix adhesion. We then observe sprout formation
in the absence of matrix ﬁbers (Fig. 6 c). In this simulation,
the tip cell is slowed by and deforms itself to accommodate a
tissue cell. The resistance from the tissue cell is enough to
redirect the leading cells and the sprout splits forming a
FIGURE 6 Numerical simulations ruling out the possibility that branching is induced solely by the tessellated structure of the stroma. For an identical
parameter set, (a) depicts a branch emerging from the main capillary as a result of anisotropies in the stroma, (b) demonstrates that the structure of the matrix
ﬁbers alone can induce branching, and (c) shows branch formation induced by resident tissue cells. No branching occurs in a homogeneous extracellular
environment due to a loss of adhesive guidance cues (d). Parameters are given in Table 1. Results suggest two plausible mechanisms for sprout branching: the
resistance created by other cells in the tissue and the structure of matrix ﬁbers. Snapshot at 16.6 days.
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branch (Supplementary Material, Movie S3). In the last
experiment, we simulate sprout formation in the absence of
both tissue-speciﬁc cells and matrix ﬁbers (Fig. 6 d). This
experiment examines sprout migration due to chemotaxis
and cell-cell adhesion alone. As may be expected, the sprout
is more linear and cells appear more elongated due to the
effects of chemotaxis, but the sprout is also larger in diameter
and much slower (see Table 2). This is because the absence
of an extracellular matrix results in a loss of adhesive guid-
ance cues generally provided by the matrix ﬁbers and con-
sequently a decrease in tip cell polarity. Interestingly, we
also observe greater persistence in sprout migration, that is,
once the sprout is oriented, it does not easily change its
direction. This is not surprising when presented with the
extensive evidence that the ECM plays a crucial role in
sprout guidance and morphology. In support of our hypoth-
esis that inhomogeneities in the stroma are a mechanism for
branching, we do not see sprout branches in the absence of
variable stromal structure. Table 2 compares the average
extension speeds and average sprout diameters for the vari-
ous stromal compositions. The rates of sprout extension for
sprouts developing without an extracellular matrix are sig-
niﬁcantly slower than those that develop with the additional
migratory cues provided by the matrix ﬁbers. Average ex-
tension speeds and average diameters are not statistically
different for sprouts growing in the absence of an ECM. The
average rate of sprout extension due to chemotaxis is 5.33
mm/day. The possibility for endothelial cells to additionally
employ extracellular matrix ﬁbers for migration results in an
18–28% increase in average extension speed. In another
series of numerical experiments, varying the compressibility
of the tissue cells does not result in any signiﬁcant differ-
ences in capillary development (results not shown).
Fig. 7 shows the development of capillary sprouts from
ﬁve endothelial cell buds (Supplementary Material, Movie
S4). As the sprouts extend toward the tumor, two neighbor-
ing sprouts anastomose forming a loop. It should be noted
that anastomosis is also the result in the literature (43,45),
where the lateral motion of the sprout tip is inﬂuenced by
positive adhesive gradients created by endothelial cell ﬁbro-
nectin uptake in the literature (43,45) and additionally by
matrix heterogeneities in Sun et al. (45). In our model, the
lateral motion of the sprouts similarly occurs as a result of
local adhesive gradients that naturally exist due to matrix
anisotropies, but also occurs as a result of the positive gra-
dients created through endothelial cell matrix degradation.
Sprout migration is further directed by endothelial cell sur-
face binding to matrix ﬁbers and by the resistance from
extravascular tissue cells. When two neighboring sprouts
encounter each other, they may or may not merge to form a
loop. That is, whether or not anastomosis will occur depends
on the dynamics of individual cell-cell and cell-matrix
binding, coupled with chemotactic and haptotactic gradients.
As with branching, loop formation emerges naturally as a
collective result of single cell behaviors and is a preferred
lower energy state structure. We would like to point out that
as the sprouts that form loops mature, blood would begin to
circulate and the forces associated with the ﬂow of blood
could cause side branching. Consistent with Kearney et al.
TABLE 2 Table comparing average migration speeds and
average sprout diameters for different stromal compositions
Stromal
composition
Avg. migration speed
mean 6 SD error
(mm/day)
Avg. sprout diameter
mean 6 SD error
(mm)
No ﬁbers, no tissue cells 5.33 6 0.075 19.29 6 0.26
Tissue cells only 5.41 6 0.074 19.08 6 0.46
Matrix ﬁbers only 6.33 6 0.131 14.41 6 0.26
With ﬁbers and tissue cells 6.84 6 0.131 14.20 6 0.70
Averages are computed from a sample of 12 simulations with identical
parameters and initial conditions. Average migration speed of the sprout is
calculated as sprout tip displacement at the end of the simulation from the
initial endothelial cell per time.
FIGURE 7 The development of capillary sprouts from ﬁve endothelial
cell buds. Two neighboring sprouts have fused together forming a loop, a
process known as anastomosis. In this simulation, anastomosis was a
preferred lower energy state structure given the known physical dynamics at
the cellular level (Supplementary Material, Movie S4). Parameters are given
in the parameter table. Snapshot at 16.6 days.
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(33), our simulations show that blood ﬂow is not necessary
for tip branching and anastomosis.
These studies indicate that the anisotropic structure of the
matrix ﬁbers strongly inﬂuences the direction andmorphology
of the migrating capillary sprout. We additionally ﬁnd that
resistance from tissue cells and endothelial cell adhesion to
matrix ﬁbers during endothelial cell migration, both alone and
in concert, is sufﬁcient to cause branching and anastomosis to
occur.We also show that regions of either high density or very
low-density matrix alone can inhibit and redirect endothelial
cell movement inducing capillary sprout branching. These
results suggest that the anisotropy of the matrix ﬁbers and the
composition of the stroma may be important mechanisms
leading to capillary sprout branching and anastomosis.
SENSITIVITY ANALYSIS
The sensitivity of the results to the particular parameter set
chosen is studied by varying one parameter at a time. First,
holding matrix ﬁber density constant, we randomly generate
alternative ECM structures as described in Modeling the
Stroma and Extracellular Matrix, and ﬁnd that our results do
not qualitatively change. Further studies show that the results
are insensitive to changes in gf, gm, and gt but cell size
depends on ge and cell shape depends on Jem. Larger values
of ge (requires more energy to grow) yield smaller cells, and
the smaller the value for Jem (stronger bond), the more
elongated the cell. Varying the chemical potential, ms,
affects both shape and size. As ms is increased by an order of
magnitude, the cells become much larger and more elongated
and sprout extension is rapid and pervasive. Increasing ms
increases the ratio of chemotactic potential to growth and
adhesion and causes the system energy changes to be
dominated by the effects of chemotaxis. Very little difference
is seen in cell size and shape until ms is decreased three
orders of magnitude, at which point cells become rounder
and sprout extension is stunted. Signiﬁcantly decreasing ms
is equivalent to having no chemotactic forces in the system.
The results are not sensitive to the value of kT until this value
is increased more than two orders of magnitude. At this point
the cells break up because larger values of kT correspond to
greater cell membrane ﬂuctuations.
DISCUSSION
Tumor angiogenesis is an important step in cancer develop-
ment. Recent experimental advances highlight the increas-
ingly complex and still largely unresolved mechanisms
driving tumor angiogenesis. We formulate speciﬁc hypoth-
eses relevant to the investigation of biomechanical and bio-
chemical mechanisms. We present a cell-based model of
tumor angiogenesis incorporating endothelial cells, stroma
tissue, ECM, and interstitial ﬂuid, as well as VEGF dy-
namics. This model reﬂects a realistic representation of the
complex and dynamic nature of the tumor microenvironment
with multiple cell types and reciprocal cellular and molecular
interactions. We demonstrate its capacity to capture realistic
dynamics and capillary sprout morphologies, such as prefer-
ential sprout migration along matrix ﬁbers, cell elongation,
and more complex events, such as branching and anasto-
mosis, that occur during angiogenesis. Our model provides a
framework for incorporating biochemistry and physics in
investigations of mechanism.
We provide evidence that differences in the matrix-
binding afﬁnity of VEGF isoforms could affect the VEGF
proﬁle and show that vastly different capillary morphologies
result in the presence of steep versus shallow extracellular
chemical gradients. Our model reproduces narrow sprouts in
the presence of steep VEGF gradients and swollen sprout
formation due to well-distributed concentrations of VEGF;
both morphologies and mechanisms are consistent with
those observed empirically by Lee et al. (32) and Gerhardt
et al. (19). These results emphasize the importance of cap-
turing not only the correct chemical proﬁle, but also the cor-
rect mechanisms inducing the extracellular chemical proﬁles.
Models of angiogenesis inducing steep gradients as a result
of VEGF uptake by a large number of cells may be neg-
lecting a vital mechanism responsible for the modulation of
endothelial cell function and vascular form. To date, mathe-
matical models have focused on the effects of tumor-secreted
VEGF in a freely diffusible form. If we hope to understand
the mechanisms regulating capillary formation, models must
incorporate other VEGF isoforms and allow for VEGF bind-
ing to and liberation from the ECM. Using this model as a
starting point, we can examine the role of different VEGF
isoforms on the spatial proﬁle of bio-available VEGF and in
regulating cellular functions and test the hypothesis that the
proteolytic release of matrix-bound VEGF isoforms natu-
rally deﬁnes a proliferating region of endothelial cells and
causes local growth differentials.
The underlying mechanisms by which a proliferating re-
gion is established during angiogenesis are still at large. We
identify biological models of angiogenesis that report cell
proliferation from distinctly different regions of a developing
sprout. Using our model, we explore the effects of various
proliferating regions on capillary sprout growth. Results
from our numerical simulations show that as the proliferating
region moves further from the sprout tip, sprout extension
is more rapid due to diminishing competing intercellular
forces. Results also show that the location of the proliferating
region does not inﬂuence sprout morphology. We demon-
strate that capillary sprout extension is signiﬁcantly more
rapid when cellular functions (migration and proliferation)
are not mutually exclusive. Our results highlight just how
tightly regulated the processes involved in angiogenesis are
and indicate the need for studies of the relative importance of
chemotaxis and proliferation on capillary development. Fur-
thermore, in these numerical experiments, the proliferating
region is a ﬁxed distance from the tip throughout the simu-
lation; however, in vivo it may be that as the sprout extends
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toward the tumor, it is the proliferating region that remains
ﬁxed—that is, the region lags further and further behind the
advancing tip (34). Coupled with our ﬁnding that sprout
extension speed is affected by the location of the prolifer-
ating region, this could possibly explain the increase in cap-
illary migration speeds seen empirically as capillary networks
approach the tumor.
The composition and structure of the stroma through
which the new capillaries must grow to reach the tumor are
highly tissue-dependent. We examine the role of tissue inho-
mogeneities by explicitly modeling the interactions between
endothelial cells and the stroma, speciﬁcally the matrix
ﬁbers, resident tissue cells, and interstitial ﬂuid. Our studies
reveal that local anisotropies in the stroma, such as variable
matrix ﬁber density and the presence of other tissue cells,
inﬂuence sprout migration and morphology during angio-
genesis and may be mechanisms for sprout branching and
anastomosis. Although the morphology of branching and
anastomosis has been fully described (17,33), little is under-
stood of the cellular and molecular mechanisms inducing the
formation of these sprout structures. In our model, anasto-
mosis and branching occur because they are preferred lower
energy state structures given the chemical and mechanical
dynamics incorporated at the cellular level. Our initial results
underscore the importance of modeling cell-matrix and cell-
cell dynamics and demonstrate that a cell-based physical
model can help provide insight into the processes controlling
angiogenesis. An in-depth study of the role of the extracel-
lular matrix and tissue composition on sprout formation,
including an investigation of the density distribution of tissue
cells and matrix ﬁbers and matrix ﬁber alignment, is the sub-
ject of work in progress.
At present, quantifying our results and validating our
model is not a straightforward task. Measurements of micro-
vessel densities over time, branching points/mm/time, and
capillary network expansion rates exist for vascular networks
that form on larger spatial scales. However, our model fo-
cuses on cell-cell and cell-matrix interactions at the very
onset of angiogenesis, when the newly formed sprouts
consist of only a few cells. Additionally, on the spatial scale
of our model, which is signiﬁcantly smaller, we do not
expect multiple branch points to form. Assays and quanti-
tative measures of early single sprout morphology under
conditions that mimic the early events that occur in vivo
during tumor-induced angiogenesis have not been well
developed. In particular, to our knowledge there has been no
systematic study of collective cell or sprout migration and
morphology that quantiﬁes the effects of chemotaxis. In
addition, experimental models that measure individual cell
migration rates cannot be directly compared to the rate at
which a capillary sprout travels or extends toward a tumor,
because cell-cell dynamics are not considered in assays of
single cell motility and during sprout extension migrating
cells are adhered to other cells that may be anchored to the
matrix or moving in different directions.
Average speeds of in vivo and in vitro vessel growth have
been reported at 0.1–0.3 mm/day (33,66). The average rate
of sprout extension in our model is considerably slower.
This difference can be attributed to a combination of several
factors. First, in our simulations, cell proliferation occurs
only in one cell. Simulating multiple proliferating regions or
proliferation in multiple cells does increase the rate of sprout
extension in our model. Fig. 4 b shows an increased sprout
extension rate when there are more proliferating cells. This
sprout has migrated the same distance as the sprout in Fig. 4
d but in only 9.4 vs. 16.6 days. However, proliferation alone
does not explain the difference in sprout migration rates.
Other factors that contribute to sprout extension speeds are
the ECM density, cell elongation, and blood ﬂow. Endothe-
lial cells can elongate up to 10 times their normal length (33)
and the density and alignment of matrix ﬁbers has a major
effect on cell migration rates (53). We are currently inves-
tigating the effects of cell elongation on sprout extension
speeds and have measured sprout speeds through matrices of
varying densities and patterns, which predict an optimal
density for maximal sprout migration speeds (unpublished
results). Another dynamic that has a signiﬁcant impact on
our sprout extension speeds is the ability to capture sheet or
cohort migration of a group of cells as is observed in vascular
sprouting (67). An important mechanism in both single cell
and collective migration is the detachment from the ECM
and subsequent retraction of the trailing edge of the cell. In
our model, we have not yet incorporated the effects of ECM
detachment and cell retraction. Preliminary studies of
simulated single cell migration and sprout formation incor-
porating these cellular motility mechanisms suggest that
sprout migration speeds may more than double.
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